The comparative effectiveness of heart disease prevention and treatment strategies.
暂无分享,去创建一个
Simon Capewell | Nicolaas P Pronk | S. Capewell | N. Pronk | D. Faith | T. Kottke | Randal J. Thomas | Randal J Thomas | Thomas E Kottke | Dennis A Faith | Courtney O Jordan | Courtney O. Jordan
[1] J. Critchley,et al. Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999 , 2004, Circulation.
[2] W. Rogers,et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. , 2000, Journal of the American College of Cardiology.
[3] Deepak L. Bhatt,et al. Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative , 2004 .
[4] D. Annane,et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis , 2004, BMJ : British Medical Journal.
[5] R. Tracy,et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.
[6] Jessica Grossmeier,et al. The Relationship Between Health Promotion Program Participation and Medical Costs:: A Dose Response , 2003, Journal of occupational and environmental medicine.
[7] Jonathan Mant,et al. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction , 1995, BMJ.
[8] Nick Freemantle,et al. β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .
[9] K. Furie,et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.
[10] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[11] P. Royle,et al. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. , 2005, Health technology assessment.
[12] Device therapy in heart failure , 2007, BMJ : British Medical Journal.
[13] R. Collins,et al. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.
[14] Robert Luben,et al. Combined Impact of Health Behaviours and Mortality in Men and Women: The EPIC-Norfolk Prospective Population Study , 2008, PLoS medicine.
[15] T. Gary,et al. Have Americans increased their fruit and vegetable intake? The trends between 1988 and 2002. , 2007, American journal of preventive medicine.
[16] R. Goetzel,et al. Heart healthy and stroke free: successful business strategies to prevent cardiovascular disease. , 2005, American journal of preventive medicine.
[17] D. Labarthe,et al. Diet and physical activity of U.S. adults with heart disease following preventive advice. , 2007, Preventive medicine.
[18] Roberto Marchioli,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .
[19] R. Collins,et al. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither , 1998, BMJ.
[20] C. Lau,et al. Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2007, Hypertension.
[21] Warren Smith,et al. Home use of automated external defibrillators for sudden cardiac arrest. , 2008, The New England journal of medicine.
[22] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[23] Task Force on Community Preventive Services. Strategies for reducing exposure to environmental tobacco smoke, increasing tobacco-use cessation, and reducing initiation in communities and health-care systems. A report on recommendations of the Task Force on Community Preventive Services. , 2000 .
[24] S. Wannamethee,et al. Physical Activity and Mortality in Older Men With Diagnosed Coronary Heart Disease , 2000, Circulation.
[25] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[26] R. Belardinelli,et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. , 1999, Circulation.
[27] D. Labarthe,et al. Prevalence of heart disease--United States, 2005. , 2007, MMWR. Morbidity and mortality weekly report.
[28] W. Weaver,et al. Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. , 2006, Journal of the American College of Cardiology.
[29] K. Bailey,et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. , 1998, Circulation.
[30] Sonia S Anand,et al. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. , 1999, JAMA.
[31] J. McMurray,et al. Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993 , 2000, Circulation.
[32] M. Piepoli,et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.
[33] A Laupacis,et al. What is the quality of life for survivors of cardiac arrest? A prospective study. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[34] D. Faust. The limits of scientific reasoning , 1984 .
[35] Roger D. White,et al. Preventing sudden death with n-3 (omega-3) fatty acids and defibrillators. , 2006, American journal of preventive medicine.
[36] Julia A. Critchley,et al. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2004 .
[37] Salim Yusuf,et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.
[38] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[39] J Lau,et al. Effects of omega-3 fatty acids on cardiovascular disease. , 2004, Evidence report/technology assessment.
[40] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[41] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[42] M. Piepoli,et al. Exercise training in patients with chronic heart failure , 2004, BMJ : British Medical Journal.
[43] Jun Ma,et al. National Trends in Statin Use by Coronary Heart Disease Risk Category , 2005, PLoS medicine.
[44] J. Critchley,et al. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.
[45] H. Krumholz,et al. Statins and Mortality Among Elderly Patients Hospitalized With Heart Failure , 2006, Circulation.
[46] M. Josephson,et al. Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake , 2005, Circulation.
[47] Douglas W Mahoney,et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.
[48] P. Jousilahti,et al. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all‐cause mortality in the middle‐aged population , 1998, Journal of hypertension.
[49] A. Owen,et al. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials , 2007, BMJ : British Medical Journal.
[50] E. Topol,et al. Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial , 2003, Circulation.
[51] A. Mokdad,et al. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. , 2006, American journal of preventive medicine.
[52] H A Feldman,et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. , 2000, JAMA.
[53] Duolao Wang,et al. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure , 2001, European journal of heart failure.
[54] S. Yusuf,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.
[55] J. Strong,et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[56] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[57] Louise B. Russell,et al. Is Prevention Better Than Cure , 1987 .
[58] F. D. H. Hall. St. Luke's Hostel , 1895 .
[59] Simon Capewell,et al. Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000 , 2004, Circulation.
[60] D. Anderson,et al. The Impact of a Worksite Health Promotion Program on Short-Term Disability Usage , 2001, Journal of occupational and environmental medicine.
[61] G. Fraser,et al. Ten years of life: Is it a matter of choice? , 2001, Archives of internal medicine.
[62] Elizabeth R DeLong,et al. ORIGINAL CONTRIBUTION Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes , 2022 .
[63] S. Yusuf,et al. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. , 2000, European heart journal.
[64] E. Antman,et al. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. , 2004, The American journal of cardiology.
[65] Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis , 2005, BMJ : British Medical Journal.
[66] Richard Doll,et al. Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.
[67] J. McMurray,et al. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994 , 1999, Heart.
[68] J P Ornato,et al. Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest Recommended Citation Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest , 2022 .
[69] K. Eagle,et al. Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes , 2004, Circulation.
[70] C. Gross,et al. Adoption of Spironolactone Therapy for Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction in the United States, 1998–2001 , 2005, Circulation.
[71] S. Ebrahim,et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.